
Farmavita.Net member is developing innovative concept for glogal branding and distribution of remedies and devices for therapy of arthritis.
Company is looking to joint-venture, collaborative development or in-licensing of non-prescrition products, on exclusive basis.
For more details please contact Farmavita.Net.
Farmavita has developed Renarthro, the synergistic combination of frankincense and myrrh extracts, with Osteol. Renarthro is formulated into capsules, ice-gel and honey. This unique innovative product is available for exclusive licensing or distributorship, for selected markets. Product details are available at www.renarthro.com or please send inquiry to info@farmavita.net.
GLOBALPHARMA Estonia is looking to acquire dossiers to produce ciprofloxacin 250 for the EU.
Please contact with your profile and more info.
Farmavita.Net member is looking for OTC medicatios against vaginal infections. Product should be approved in EU and have up-to-date CTD Dossier. Licensee will also close exclusive supply agreement with licensor.
Examples of suitable products are monoproducts or combinations of fluconazole, itraconacole, clindamycine pessaries and cream, as well as smiilar products.
WE REQUIRE PLANT PROVEN COMMERCIAL TECHNOLOGY TO MANAUFACTURE SPECTINOMYCIN HCL IN INDIA . TECHNOLOGY LICENCENSORS/MANUFACTURING COMPANIES/CONSULTANTS TO SUBMIT THEIR TECHNICAL AND COMMERCIAL PROFILE AND BUSINESS TERMS.
CONTACT; MR.ARVIND GANDHI -GM MKTG ( API AND FINE CHEMICALS) ASENCE PHARMA PVT.LTD.,MUMBAI.
EMAIL; saramvitc@asedvnsmc.com
The gradual spread of software automation in drug development may be
getting a boost from open source systems. Most e-clinical systems
today--from data capture and storage to trial management and
operations--are proprietary, despite the excellent work that solutions
providers have done to make their products compatible with existing
standards-based and de facto standard industry systems.

Micro- and nanoscale technologies are emerging as powerful enabling tools for tissue engineering and drug discovery. In tissue engineering, micro- and nanotechnologies can be used to fabricate biomimetic scaffolds with increased complexity and vascularization.
The whole 16 pages article is available for download at Downloads section of Farmavita.Net.
18-19th June, Frankfurt, Germany
The game in the chemical sales and marketing sector has changed over the past couple of years since processes have become faster and competition sharper. Also, as customers are becoming even more influential and empowered in making decisions, the need for change has never been more critical. Only those who adapt to the current challenging chemistry landscape will prove their readiness to compete successfully.
This report gives a thorough analysis of the refurbished medical devices market segment. The regulatory environment for refurbished devices is assessed in 92 countries. Opportunities within this market are assessed by device type and by country. A thorough analysis of who the end users for refurbished devices are and what their demands are, with strategies and best practices for growth discussed.
Invite friends and business partners to join Farmavita.NetRecommend Farmavita.Net and expand your network! Go to "Expand Your Network" at Member Menu. There is invitation tool which will help you to import your e-mail addresses from internet or desktop address books. You will be connected to every invited person and also earn two "Good Karma" points for every new member. |